AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Transgene

Capital/Financing Update Jan 7, 2025

1715_rns_2025-01-07_4f24df2f-29de-4be5-bd65-be61411bea4a.pdf

Capital/Financing Update

Open in Viewer

Opens in native device viewer

PRESS RELEASE

Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2024

Strasbourg, January 7, 2025 – 06:00 pm CET

Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of December 31, 2024, the following resources were managed through the liquidity account:

  • 359,661 shares
  • € 80,653.30

In the second half of 2024, a total of:

Purchases 250,777
shares
€ 243,947.38 1,154
market transactions
Sales 229 905
shares
€ 230,275.17 1,081
market transactions

It is recalled that when the liquidity program was initially established in 2016, the following resources were made available:

  • € 500,000.00

At the time the liquidity program was transferred to Natixis Oddo BHF SCA on January 2, 2020, the resources managed through the liquidity account consisted of:

  • 164,183 shares
  • € 246,158.00

Contacts

Transgene:

Lucie LARGUIER CFO +33 (0)3 88 27 91 00 [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.